Carregant...

Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients

INTRODUCTION: In the past, antiviral therapy has been given to 15% to 30% of patients infected with hepatitis C virus (HCV). The efficacy of therapy has recently improved with the addition of ribavirin and pegylated interferon. The aim of the present study was to identify the clinical, socioeconomic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Witkos, Maciej, Yi, Qi-Long, Heathcote, Jenny, Kapral, Moira K, Krahn, Murray D
Format: Artigo
Idioma:Inglês
Publicat: Pulsus Group Inc 2006
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2538973/
https://ncbi.nlm.nih.gov/pubmed/16482237
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!